CorMedix (CRMD) Retained Earnings (2016 - 2025)
Historic Retained Earnings for CorMedix (CRMD) over the last 13 years, with Q3 2025 value amounting to -$190.6 million.
- CorMedix's Retained Earnings rose 4602.15% to -$190.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$190.6 million, marking a year-over-year increase of 4602.15%. This contributed to the annual value of -$339.6 million for FY2024, which is N/A changed from last year.
- Per CorMedix's latest filing, its Retained Earnings stood at -$190.6 million for Q3 2025, which was up 4602.15% from -$299.2 million recorded in Q2 2025.
- CorMedix's 5-year Retained Earnings high stood at -$190.6 million for Q3 2025, and its period low was -$353.1 million during Q3 2024.
- In the last 5 years, CorMedix's Retained Earnings had a median value of -$280.6 million in 2022 and averaged -$281.7 million.
- In the last 5 years, CorMedix's Retained Earnings plummeted by 1787.2% in 2024 and then skyrocketed by 4602.15% in 2025.
- CorMedix's Retained Earnings (Quarter) stood at -$245.7 million in 2021, then fell by 12.09% to -$275.4 million in 2022, then dropped by 11.47% to -$306.9 million in 2023, then fell by 10.65% to -$339.6 million in 2024, then soared by 43.88% to -$190.6 million in 2025.
- Its last three reported values are -$190.6 million in Q3 2025, -$299.2 million for Q2 2025, and -$319.0 million during Q1 2025.